Skip to content
Search

Latest Stories

Follow Us:
Top Stories

How Expiring Subsidies and Medicaid Cuts Could Reshape U.S. Access to Care

News

A stethoscope, calculator, pills, and cash.

As ACA subsidies expire and Medicaid rolls shrink, millions could face higher premiums or lose coverage, reigniting a national healthcare debate.

Getty Images, athima tongloom

Current Issue

In the coming year, millions of Americans could see their health insurance premiums rise, or lose coverage entirely, as key federal supports for affordable care are set to expire. The American Rescue Plan Act of 2021 (ARPA) subsidies under the Affordable Care Act (ACA) marketplace, which were later extended by the Inflation Reduction Act, are scheduled to expire at the end of 2025. According to one analysis, if these enhanced subsidies expire, premiums on average could increase by 25-100 percent. At the same time, several states are reducing Medicaid rolls following the end of the pandemic-era continuous coverage requirement. Over 25 million people had been disenrolled from Medicaid and CHIP during this process in 2024. Together, these changes could redefine U.S. healthcare access, reigniting debates about public health and fiscal restraint.

Background

The ACA, passed in 2010, aimed to make health insurance more accessible for millions of uninsured Americans by expanding Medicaid eligibility and creating subsidized plans under the premium tax credit. The ARPA of 2021 significantly increased those marketplace subsidies, eliminating the 400% of poverty threshold for eligibility and reducing the percentage of income that enrollees must pay in premiums. As a result, the number of people eligible for marketplace subsidies increased from 18.1 million to 21.8 million from 2020-2021. Meanwhile, pandemic policies prevented states from disenrolling almost all Medicaid and CHIP enrollees for over three years. When this continuous coverage requirement ended in April of 2023, states began to reevaluate the eligibility of tens of millions of people. The expiration of ARPA temporary subsidies combined with the end of continuous Medicaid coverage set the stage for a contentious healthcare market next year.


Arguments for and Against Medicaid Cuts

Supporters of allowing the subsidies to expire and tightening Medicaid eligibility argue that these measures are necessary to reduce federal spending and restore fiscal discipline. For example, one analyst reported that ACA-related premium tax credits and related spending accounted for about 6% of federal healthcare spending in 2023, and projections show it shrinking further. Fiscal conservatives argue that the temporary nature of the pandemic-era expansions was clear from the start, and that continuing them indefinitely would distort the original design of the ACA and burden taxpayers.

Opponents of the cuts, however, warn that cutting back subsidies and shrinking Medicaid benefits would reverse more than a decade of progress in reducing the rate of uninsurance. One article estimates that 4-5 million additional Americans could become uninsured. Additionally, disenrollment data shows that procedural and administrative barriers have already contributed to millions of terminations in Medicaid, even where people may still be eligible. These critics argue that healthcare coverage is a public good, and that covering more people reduces uncompensated care costs for hospitals, improves population health outcomes, and increases economic stability for families.

Political and Public Health Implications

The debate over healthcare subsidies and Medicaid reflects a broader ideological divide in Washington. For the most part,Democrats favor extending or making the enhanced subsidies permanent, while Republicans emphasize deficit reduction and returning to pre-pandemic policy norms. This issue has become a key point of focus during the government shutdown.

From a public health perspective, the health outcomes related to this situation are equally important. If subsidies lapse and Medicaid cuts continue, the uninsured rate will likely rise, threatening preventative care, maternal health, and chronic disease management. Hospitals in rural and underserved areas which are already operating under thin margins could face higher uncompensated care burdens, potentially forcing reduction in services or closures. This is especially important as underserved communities and those of color who have already seen disparate impacts during the pandemic may be more vulnerable to coverage loss.

Conclusion

As the 2025 expiration date approaches, lawmakers must make a choice: whether to extend federal assistance and maintain current levels of coverage, or allow the system to contract in the name of fiscal prudence. This decision will shape the affordability of healthcare for millions. Whether Congress chooses to sustain or scale back these programs, one thing is clear: the future of U.S. healthcare once again hangs in the balance.


How Expiring Subsidies and Medicaid Cuts Could Reshape U.S. Access to Care was originally published by the Alliance for Civic Engagement and is republished with permission.


Read More

As Temperatures Rise and Federal Funding Falls, Drowning Risks Grow
a group of kids in a pool
Photo by Kevin Paes on Unsplash

As Temperatures Rise and Federal Funding Falls, Drowning Risks Grow

July 25 marked World Drowning Day. More than 4000 people die from unintentional drowning in the United States each year. This translates into an average of 11 drowning deaths per day. Children ages one to four are at greatest risk, making drowning the leading cause of death for that group and the second leading cause of death for children ages five to 14.

Two emerging trends could make those numbers worse: federal funding cuts that have weakened drowning prevention efforts and hotter summers that are driving more people to water to cool off. Together, these trends threaten to deepen long-standing disparities that already place Black, Indigenous, autistic, and low-income communities at greater risk.

Keep ReadingShow less
FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.

The FDA’s changing drug approval policies raise concerns about political influence, scientific standards, drug safety, and the future of U.S. pharmaceutical regulation.

JHVEPhoto/Getty Images

FDA Turmoil: Political Interference Threatens Drug Safety Standards

Over the past three decades, drug development in the United States accelerated dramatically. Industry spending increased tenfold between the 1980s and 2019; the number of manufacturers grew; clinical trials became more sophisticated; and new technologies and precision medicines emerged. The Food and Drug Administration kept pace, building processes, standards, and a scientific culture that supported this rapid innovation. It offered pharmaceutical companies a predictable regulatory environment and a level playing field, producing substantial benefits for consumers and researchers alike.

In little more than a year, however, the Trump administration has upended many of these FDA norms. It has tied certain drug approvals to political considerations through a new, opaque program; imposed labeling changes without new scientific evidence; forced out experienced career scientists; replaced respected experts on advisory panels; and promoted unproven therapies. While some of these moves have drawn limited media attention, most have escaped public notice—even though they threaten national health standards and consumer safety. And legal guardrails may be too weak to prevent or limit their effects.

Keep ReadingShow less
Gynecologist doing ultrasound of pregnant woman in hospital.

Rural hospital labor and delivery closures are creating maternity care deserts—and costing communities physicians, jobs, families, and economic investment.

Maskot/Getty Images

No Doctor, No Delivery, No Future

Today, less than half of rural hospitals in the U.S. still offer labor and delivery services, and since 2020, 139 of them have stopped delivering babies altogether. That's usually treated as public health statistic. It's also an economic one. Each closure doesn't just push expectant mothers into longer drives to the hospital, it pushes out physicians, jobs, young families, and the investment that follows them. So, what happens to a town after it loses its only labor and delivery unit?

The answer, it turns out, is a lot more than a longer drive to the hospital. More than a third of U.S. counties, 35.1 percent by the most recent national count, are now what researchers call maternity care deserts: places with no hospital or birth center offering obstetric care and no obstetric clinicians at all. Since the end of 2020, 139 rural hospitals have stopped delivering babies, and today less than half of rural hospitals nationwide still offer labor and delivery services.

Keep ReadingShow less
A Senior Man Using A Laptop Computer And Paying Bills With Nurse

H.R. 1 could leave millions uninsured, increase healthcare costs, strain hospitals, and affect even Americans with employer-sponsored health insurance.

miniseries/Getty Images

Not All Change Is Good: Medicaid, Medicare Shifts Are Everyone’s Problem

Like 155 million other Americans, I get my health insurance coverage through my employer. The millions like me who are not on Medicaid or Medicare may not be closely tracking the massive changes coming to public insurance programs because of H.R.1 (also known as President Donald Trump’s “One Big Beautiful Bill Act”).

But over the next decade, it’s estimated that up to 10 million people may lose health insurance because of changes to Medicare and Medicaid.

Keep ReadingShow less